JCR Pharmaceuticals Co., Ltd. (TYO:4552)
Japan · Delayed Price · Currency is JPY 504.00
-13.00 (-2.51%)
Jul 30, 2026, 3:30 PM JST
JCR Pharmaceuticals Market Cap
JCR Pharmaceuticals has a market cap or net worth of 63.08 billion as of July 29, 2026. Its market cap has decreased by -26.35% in one year.
Market Cap
63.08B
Enterprise Value
103.38B
Revenue
40.32B
Ranking
n/a
PE Ratio
28.95
Stock Price
504.00
ChartMarket Cap Chart
Since March 22, 2011, JCR Pharmaceuticals's market cap has increased from 28.73B to 63.08B, an increase of 119.57%. That is a compound annual growth rate of 5.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 63.08B | -27.37% |
| Dec 30, 2025 | 86.85B | 17.45% |
| Dec 30, 2024 | 73.95B | -49.44% |
| Dec 29, 2023 | 146.26B | -30.27% |
| Dec 30, 2022 | 209.74B | -23.79% |
| Dec 30, 2021 | 275.22B | -8.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.63T |
| Otsuka Holdings | 6.04T |
| Daiichi Sankyo Company | 5.16T |
| Astellas Pharma | 4.11T |
| Kyowa Kirin | 1.41T |
| Ono Pharmaceutical | 1.17T |
| Santen Pharmaceutical | 649.97B |
| Perseus Proteomics | 2.62B |